Argen X Valuation
| ARGX Stock | EUR 582.60 17.80 3.15% |
At this time, the firm appears to be undervalued. Argen X shows a prevailing Real Value of €608.49 per share. The current price of the firm is €582.6. Our model approximates the value of Argen X from analyzing the firm fundamentals such as operating margin of (2.97) %, and Return On Equity of -0.31 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Argen X's price fluctuation is very steady at this time. Calculation of the real value of Argen X is based on 3 months time horizon. Increasing Argen X's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Argen stock is determined by what a typical buyer is willing to pay for full or partial control of Argen X. Since Argen X is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Argen Stock. However, Argen X's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 582.6 | Real 608.49 | Hype 582.6 | Naive 577.2 |
The intrinsic value of Argen X's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Argen X's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Argen X helps investors to forecast how Argen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Argen X more accurately as focusing exclusively on Argen X's fundamentals will not take into account other important factors: Argen X Total Value Analysis
Argen X is presently projected to have takeover price of 17.99 B with market capitalization of 19.43 B, debt of 9.7 M, and cash on hands of 2.6 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Argen X fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.99 B | 19.43 B | 9.7 M | 2.6 B |
Argen X Investor Information
About 41.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 11.03. Argen X had not issued any dividends in recent years. Based on the key measurements obtained from Argen X's financial statements, Argen X is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Argen X Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Argen X has an asset utilization ratio of 17.45 percent. This connotes that the Company is making €0.17 for each dollar of assets. An increasing asset utilization means that Argen X is more efficient with each dollar of assets it utilizes for everyday operations.Argen X Ownership Allocation
Argen X holds a total of 55.47 Million outstanding shares. 30% of Argen X outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Argen X Profitability Analysis
The company reported the revenue of 497.28 M. Net Loss for the year was (408.26 M) with loss before overhead, payroll, taxes, and interest of (52.25 M).About Argen X Valuation
The stock valuation mechanism determines Argen X's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Argen X based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Argen X. We calculate exposure to Argen X's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Argen X's related companies.argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. ARGENX SE operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 650 people.
8 Steps to conduct Argen X's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Argen X's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Argen X's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Argen X's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Argen X's revenue streams: Identify Argen X's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Argen X's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Argen X's growth potential: Evaluate Argen X's management, business model, and growth potential.
- Determine Argen X's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Argen X's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Argen Stock Analysis
When running Argen X's price analysis, check to measure Argen X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argen X is operating at the current time. Most of Argen X's value examination focuses on studying past and present price action to predict the probability of Argen X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argen X's price. Additionally, you may evaluate how the addition of Argen X to your portfolios can decrease your overall portfolio volatility.